Sugi Predict

Sugi Predict / Compounds / SCHEMBL1004255

SCHEMBL1004255

SCHEMBL1004255

CC(C)(O)c1ccc(-c2nc(-c3ccc(F)cc3)oc2Sc2ccc(Cl)cc2F)cn1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 5/20 0.73
▸ KCNH2 Q12809 4/20 0.73
▸ TP53 P04637 5/20 0.35
▸ MAPT P10636 4/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ GABRA1 P14867 4/20 0.34
▸ GABRG2 P18507 4/20 0.34
▸ GABRB3 P28472 4/20 0.34
▸ GABRA5 P31644 4/20 0.34
▸ GABRA3 P34903 4/20 0.34
▸ GABRA2 P47869 2/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ TSHR P16473 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ MAPK11 Q15759 1/20 0.32
▸ MAPK14 Q16539 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1004691 0.93 FAAH (0.68) FAAHKCNH2TP53MAPTKDM4E
SCHEMBL1000402 0.88 FAAH (0.67) FAAHKCNH2TP53MAPTKDM4E
SCHEMBL1002693 0.86 FAAH (0.79) FAAHKCNH2TP53MAPTKDM4E
SCHEMBL1001251 0.85 FAAH (1.00) FAAHKCNH2TP53MAPTKDM4E
SCHEMBL1002336 0.84 FAAH (0.79) FAAHKCNH2TP53MAPTKDM4E
SCHEMBL1001433 0.83 FAAH (0.68) FAAHKCNH2TP53MAPTKDM4E
SCHEMBL1961921 0.83 FAAH (0.68) FAAHKCNH2TP53MAPTKDM4E
SCHEMBL1002448 0.83 FAAH (0.89) FAAHKCNH2TP53MAPTKDM4E
SCHEMBL1000363 0.81 FAAH (0.70) FAAHKCNH2TP53MAPTKDM4E
SCHEMBL1004756 0.81 FAAH (0.65) FAAHKCNH2GABRA1GABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9045467-B2 Oxazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2015-06-02 — — US claimed
US-20140171437-A1 OXAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. (US) 2014-06-19 — — US claimed
EP-2321288-B1 OXAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME (US) 2014-03-19 — — EP claimed
US-8673941-B2 Oxazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2014-03-18 — — US claimed
JP-2011529965-A — — 2011-12-15 — — JP claimed
US-20110144119-A1 OXAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME LLC 2011-06-16 — — US claimed
EP-2321288-A1 OXAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH Merck & Co., Inc. (US) 2011-05-18 — — EP claimed
US-20110021531-A1 OXAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-01-27 — — US claimed
WO-2010017079-A1 OXAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK & CO., INC. (US) 2010-02-11 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144119-A1 OXAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH FAAH, FAAH2, ALOX5 FAAH 1/4885KCNH2 2570/4885TP53 4858/4885
US-20140171437-A1 OXAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH FAAH, FAAH2, ALOX5 FAAH 1/4885KCNH2 2570/4885TP53 4858/4885
US-20110021531-A1 OXAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH FAAH, FAAH2, ALOX5 FAAH 1/4885KCNH2 2037/4885TP53 4872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.